Karuna Therapeutics Inc (KRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 185,823 | 184,575 | 263,603 | 562,921 | 248,329 |
| Marketable Securities | 1,076,990 | 1,157,039 | 1,172,907 | 911,794 | 875,715 |
| Receivables | N/A | N/A | N/A | N/A | 57 |
| Other current assets | 12,507 | 10,907 | 625 | 625 | 1,562 |
| TOTAL | $1,315,313 | $1,365,397 | $1,451,947 | $1,507,759 | $1,154,769 |
| Non-Current Assets | |||||
| PPE Net | 5,424 | 4,715 | 4,182 | 3,721 | 3,201 |
| Other Non-Current Assets | 15,472 | 14,985 | 15,974 | 4,688 | 5,364 |
| TOTAL | $20,896 | $19,700 | $20,156 | $8,409 | $8,565 |
| Total Assets | $1,336,209 | $1,385,097 | $1,472,103 | $1,516,168 | $1,163,334 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,783 | 2,939 | 1,102 | 476 | 2,379 |
| Accrued Expenses | 41,609 | 44,129 | 35,524 | 22,694 | 29,285 |
| Other current liabilities | 16,894 | 104 | N/A | N/A | N/A |
| TOTAL | $68,129 | $48,968 | $38,603 | $25,237 | $33,946 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 13,845 | 13,813 | 13,937 | 2,796 | 3,150 |
| TOTAL | $13,845 | $13,813 | $13,937 | $2,796 | $3,150 |
| Total Liabilities | $81,974 | $62,781 | $52,540 | $28,033 | $37,096 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 38,148 | 37,727 | 37,668 | 37,444 | 34,515 |
| Common Shares | 4 | 4 | 4 | 4 | 3 |
| Retained earnings | -997,887 | -884,063 | -764,944 | -661,781 | -564,207 |
| Other shareholders' equity | 687 | -2,929 | -3,642 | -1,615 | -3,290 |
| TOTAL | $1,254,235 | $1,322,316 | $1,419,563 | $1,488,135 | $1,126,238 |
| Total Liabilities And Equity | $1,336,209 | $1,385,097 | $1,472,103 | $1,516,168 | $1,163,334 |